190 related articles for article (PubMed ID: 26686625)
1. RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability.
Chen E; Ahn JS; Sykes DB; Breyfogle LJ; Godfrey AL; Nangalia J; Ko A; DeAngelo DJ; Green AR; Mullally A
Cell Rep; 2015 Dec; 13(11):2345-2352. PubMed ID: 26686625
[TBL] [Abstract][Full Text] [Related]
2. RECQL5 plays an essential role in maintaining genome stability and viability of triple-negative breast cancer cells.
Peng J; Tang L; Cai M; Chen H; Wong J; Zhang P
Cancer Med; 2019 Aug; 8(10):4743-4752. PubMed ID: 31231988
[TBL] [Abstract][Full Text] [Related]
3. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments.
Hu Y; Raynard S; Sehorn MG; Lu X; Bussen W; Zheng L; Stark JM; Barnes EL; Chi P; Janscak P; Jasin M; Vogel H; Sung P; Luo G
Genes Dev; 2007 Dec; 21(23):3073-84. PubMed ID: 18003859
[TBL] [Abstract][Full Text] [Related]
4. RECQL5 plays co-operative and complementary roles with WRN syndrome helicase.
Popuri V; Huang J; Ramamoorthy M; Tadokoro T; Croteau DL; Bohr VA
Nucleic Acids Res; 2013 Jan; 41(2):881-99. PubMed ID: 23180761
[TBL] [Abstract][Full Text] [Related]
5. Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.
Popuri V; Tadokoro T; Croteau DL; Bohr VA
Crit Rev Biochem Mol Biol; 2013; 48(3):289-99. PubMed ID: 23627586
[TBL] [Abstract][Full Text] [Related]
6. Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination with Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines.
Szymańska J; Smolewski P; Majchrzak A; Cebula-Obrzut B; Chojnowski K; Treliński J
Adv Clin Exp Med; 2015; 24(2):195-202. PubMed ID: 25931349
[TBL] [Abstract][Full Text] [Related]
7. A Blm-Recql5 partnership in replication stress response.
Lu X; Lou H; Luo G
J Mol Cell Biol; 2011 Feb; 3(1):31-8. PubMed ID: 21278449
[TBL] [Abstract][Full Text] [Related]
8. Recruitment and retention dynamics of RECQL5 at DNA double strand break sites.
Popuri V; Ramamoorthy M; Tadokoro T; Singh DK; Karmakar P; Croteau DL; Bohr VA
DNA Repair (Amst); 2012 Jul; 11(7):624-35. PubMed ID: 22633600
[TBL] [Abstract][Full Text] [Related]
9. A variant of the breast cancer type 2 susceptibility protein (BRC) repeat is essential for the RECQL5 helicase to interact with RAD51 recombinase for genome stabilization.
Islam MN; Paquet N; Fox D; Dray E; Zheng XF; Klein H; Sung P; Wang W
J Biol Chem; 2012 Jul; 287(28):23808-18. PubMed ID: 22645136
[TBL] [Abstract][Full Text] [Related]
10. Recql5 plays an important role in DNA replication and cell survival after camptothecin treatment.
Hu Y; Lu X; Zhou G; Barnes EL; Luo G
Mol Biol Cell; 2009 Jan; 20(1):114-23. PubMed ID: 18987339
[TBL] [Abstract][Full Text] [Related]
11. RECQL5 controls transcript elongation and suppresses genome instability associated with transcription stress.
Saponaro M; Kantidakis T; Mitter R; Kelly GP; Heron M; Williams H; Söding J; Stewart A; Svejstrup JQ
Cell; 2014 May; 157(5):1037-49. PubMed ID: 24836610
[TBL] [Abstract][Full Text] [Related]
12. Expression of human RECQL5 in Saccharomyces cerevisiae causes transcription defects and transcription-associated genome instability.
Lafuente-Barquero J; Svejstrup JQ; Luna R; Aguilera A
Mol Genet Genomics; 2024 May; 299(1):59. PubMed ID: 38796829
[TBL] [Abstract][Full Text] [Related]
13. Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survival.
Rubert J; Qian Z; Andraos R; Guthy DA; Radimerski T
BMC Cancer; 2011 Jan; 11():24. PubMed ID: 21247487
[TBL] [Abstract][Full Text] [Related]
14. JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response.
Chen E; Ahn JS; Massie CE; Clynes D; Godfrey AL; Li J; Park HJ; Nangalia J; Silber Y; Mullally A; Gibbons RJ; Green AR
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15190-5. PubMed ID: 25288776
[TBL] [Abstract][Full Text] [Related]
15. RecQL5 promotes genome stabilization through two parallel mechanisms--interacting with RNA polymerase II and acting as a helicase.
Islam MN; Fox D; Guo R; Enomoto T; Wang W
Mol Cell Biol; 2010 May; 30(10):2460-72. PubMed ID: 20231364
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors.
Choong ML; Pecquet C; Pendharkar V; Diaconu CC; Yong JW; Tai SJ; Wang SF; Defour JP; Sangthongpitag K; Villeval JL; Vainchenker W; Constantinescu SN; Lee MA
J Cell Mol Med; 2013 Nov; 17(11):1397-409. PubMed ID: 24251790
[TBL] [Abstract][Full Text] [Related]
17. Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
Liao WQ; Qi YL; Wang L; Dong XM; Xu T; Ding CD; Liu R; Liang WC; Lu LT; Li H; Li WF; Luo GB; Lu XC
World J Gastroenterol; 2015 Sep; 21(36):10375-84. PubMed ID: 26420964
[TBL] [Abstract][Full Text] [Related]
18. Functional inhibition of RECQL5 helicase elicits non-homologous end joining response and sensitivity of breast cancers to PARP inhibitor.
Philip KT; Dutta K; Chakraborty S; Patro BS
Int J Biochem Cell Biol; 2023 Aug; 161():106443. PubMed ID: 37392863
[TBL] [Abstract][Full Text] [Related]
19. Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice.
Akada H; Akada S; Hutchison RE; Mohi G
Leukemia; 2014 Aug; 28(8):1627-35. PubMed ID: 24480985
[TBL] [Abstract][Full Text] [Related]
20. RecQ family helicases in genome stability: lessons from gene disruption studies in DT40 cells.
Seki M; Otsuki M; Ishii Y; Tada S; Enomoto T
Cell Cycle; 2008 Aug; 7(16):2472-8. PubMed ID: 18719387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
